These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


378 related items for PubMed ID: 10336568

  • 1. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, Johnson EC, Kuhn R, Urwyler S, Sauer D, Portet C, Schmutz M, Nicoletti F, Flor PJ.
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [Abstract] [Full Text] [Related]

  • 2. (2S,1'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine, a potent and selective antagonist of type 2 metabotropic glutamate receptors.
    Thomsen C, Bruno V, Nicoletti F, Marinozzi M, Pellicciari R.
    Mol Pharmacol; 1996 Jul; 50(1):6-9. PubMed ID: 8700119
    [Abstract] [Full Text] [Related]

  • 3. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL, Bleisch TJ, Arnold MB, Kennedy JH, Wright RA, Johnson BG, Tizzano JP, Helton DR, Kallman MJ, Schoepp DD, Hérin M.
    J Med Chem; 1998 Jan 29; 41(3):358-78. PubMed ID: 9464367
    [Abstract] [Full Text] [Related]

  • 4. Neuroprotective effect of (R, S)-4-phosphonophenylglycine against neuronal damage associated with homocysteic acid-induced seizures in immature rats.
    Langmeier M, Folbergrová J, Haugvicová R, Riljak V.
    Prague Med Rep; 2006 Jan 29; 107(4):421-32. PubMed ID: 17402555
    [Abstract] [Full Text] [Related]

  • 5. Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats.
    Johansen PA, Chase LA, Sinor AD, Koerner JF, Johnson RL, Robinson MB.
    Mol Pharmacol; 1995 Jul 29; 48(1):140-9. PubMed ID: 7623768
    [Abstract] [Full Text] [Related]

  • 6. mGluR-evoked augmentation of receptor-mediated cyclic AMP formation in neonatal and adult rat striatum.
    Cartmell J, Schaffhauser H, Wichmann J, Mutel V.
    Br J Pharmacol; 1997 Aug 29; 121(7):1263-8. PubMed ID: 9257902
    [Abstract] [Full Text] [Related]

  • 7. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity.
    Orlando LR, Alsdorf SA, Penney JB, Young AB.
    Exp Neurol; 2001 Jan 29; 167(1):196-204. PubMed ID: 11161608
    [Abstract] [Full Text] [Related]

  • 8. L-CCG-I activates group III metabotropic glutamate receptors in the hippocampal CA3 region.
    Kirschstein T, von der Brelie C, Steinhäuser M, Vinçon A, Beck H, Dietrich D.
    Neuropharmacology; 2004 Aug 29; 47(2):157-62. PubMed ID: 15223294
    [Abstract] [Full Text] [Related]

  • 9. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
    Cartmell J, Adam G, Chaboz S, Henningsen R, Kemp JA, Klingelschmidt A, Metzler V, Monsma F, Schaffhauser H, Wichmann J, Mutel V.
    Br J Pharmacol; 1998 Feb 29; 123(3):497-504. PubMed ID: 9504391
    [Abstract] [Full Text] [Related]

  • 10. Distinct influence of the group III metabotropic glutamate receptor agonist (R,S)-4-phosphonophenylglycine [(R,S)-PPG] on different forms of neuronal damage.
    Henrich-Noack P, Flor PJ, Sabelhaus CF, Prass K, Dirnagl U, Gasparini F, Sauter A, Rudin M, Reymann KG.
    Neuropharmacology; 2000 Mar 03; 39(5):911-7. PubMed ID: 10699457
    [Abstract] [Full Text] [Related]

  • 11. Coupling of metabotropic glutamate receptor 8 to N-type Ca2+ channels in rat sympathetic neurons.
    Guo J, Ikeda SR.
    Mol Pharmacol; 2005 Jun 03; 67(6):1840-51. PubMed ID: 15755905
    [Abstract] [Full Text] [Related]

  • 12. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity.
    Nielsen EO, Varming T, Mathiesen C, Jensen LH, Moller A, Gouliaev AH, Wätjen F, Drejer J.
    J Pharmacol Exp Ther; 1999 Jun 03; 289(3):1492-501. PubMed ID: 10336544
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes.
    Nishi N, Odagaki Y, Koyama T.
    Br J Pharmacol; 2000 Aug 03; 130(7):1664-70. PubMed ID: 10928972
    [Abstract] [Full Text] [Related]

  • 14. Selective activation of group III metabotropic glutamate receptors by L-(+)-2-amino-4-phosphonobutryic acid protects the nigrostriatal system against 6-hydroxydopamine toxicity in vivo.
    Vernon AC, Zbarsky V, Datla KP, Dexter DT, Croucher MJ.
    J Pharmacol Exp Ther; 2007 Jan 03; 320(1):397-409. PubMed ID: 17012606
    [Abstract] [Full Text] [Related]

  • 15. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties.
    Weiser T, Brenner M, Palluk R, Bechtel WD, Ceci A, Brambilla A, Ensinger HA, Sagrada A, Wienrich M.
    J Pharmacol Exp Ther; 1999 Jun 03; 289(3):1343-9. PubMed ID: 10336525
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase.
    Monn JA, Valli MJ, Johnson BG, Salhoff CR, Wright RA, Howe T, Bond A, Lodge D, Spangle LA, Paschal JW, Campbell JB, Griffey K, Tizzano JP, Schoepp DD.
    J Med Chem; 1996 Jul 19; 39(15):2990-3000. PubMed ID: 8709133
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of mGluR8 in pilocarpine epileptic rats.
    Kral T, Erdmann E, Sochivko D, Clusmann H, Schramm J, Dietrich D.
    Synapse; 2003 Mar 15; 47(4):278-84. PubMed ID: 12539201
    [Abstract] [Full Text] [Related]

  • 18. Activation of spinal metabotropic glutamate receptors elicits cardiovascular responses in pentobarbital anesthetized rats.
    Celuch SM, García Mdel C.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Oct 15; 366(4):343-9. PubMed ID: 12237748
    [Abstract] [Full Text] [Related]

  • 19. Activation of Group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake.
    Zhou F, Yao HH, Wu JY, Yang YJ, Ding JH, Zhang J, Hu G.
    J Neurosci Res; 2006 Aug 01; 84(2):268-77. PubMed ID: 16752416
    [Abstract] [Full Text] [Related]

  • 20. [3H]LY341495 binding to group II metabotropic glutamate receptors in rat brain.
    Wright RA, Arnold MB, Wheeler WJ, Ornstein PL, Schoepp DD.
    J Pharmacol Exp Ther; 2001 Aug 01; 298(2):453-60. PubMed ID: 11454905
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.